Market News
Latest news from Stock markets.
Constellation Energy: AI Makes Nuclear Power A Profit Magnet
Constellation Energy (CEG) is a BUY, driven by rising U.S. electricity prices and unique nuclear asset longevity. CEG's fully depreciated nuclear fleet positions it to rapidly convert electricity price increases into profit, outpacing revenue growth. Long-term contracts create a lag in financials, but the moving average of realized prices will rise with market rates.
...keep reeding on seekingalpha.com
1 Unstoppable Stock to Buy Before It Joins Nvidia, Apple, Microsoft, and Alphabet in the $3 Trillion Club
Amazon's stock success boils down to AWS and advertising. Its growth rate has accelerated in recent quarters.
...keep reeding on fool.com
Oil News: Crude Oil Futures Break 50-Day MA as Supply Fears Build
Light crude oil futures break above 50-day MA at $59.67. Fed rate cuts and supply risks fuel rally, but can buyers hold the line?
...keep reeding on fxempire.com
GRNY: Bullish Heading In 2026 As AI Boom Continues (Rating Upgrade)
Fundstrat Granny Shots US Large Cap ETF (GRNY) delivers market-beating returns with a diversified, theme-driven approach focused on AI, energy, and fintech. GRNY's risk profile is lower than ARKK, with only 27% of assets in its top ten holdings and minimal turnover, supporting volatility tolerance. AI, energy infrastructure, and fintech exposure position GRNY for continued growth in 2026, leveraging secular trends in technology and blockchain.
...keep reeding on seekingalpha.com
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
Vertex Pharmaceuticals is the worldwide leader in cystic fibrosis treatment -- and its drugs have generated blockbuster revenue. The company has expanded into other therapeutic areas in recent years and has won approval for treatments for blood disorders and pain management.
...keep reeding on fool.com
1 Super Semiconductor Stock to Buy Hand Over Fist in 2026, According to Wall Street
TSMC's new technology will be critical in sustaining the artificial intelligence (AI) buildout. The companies TSMC provides chips to project strong growth over the next five years.
...keep reeding on fool.com
Moelis & Company: Dividend Income Appears More Attractive Than Current Growth Prospects
Moelis & Company (MC) remains a Hold, as macro uncertainty and lack of near-term catalysts temper upside potential. MC's strong shareholder policies and history of special dividends support continued holding, despite recent CEO transition. Leadership change to co-founder Navid Mahmoodzadegan is not expected to disrupt operations, but adds minor uncertainty.
...keep reeding on seekingalpha.com
SK hynix Honored with Two Major Titles at GSA Awards 2025
Company named "Best Financially Managed Semiconductor Company (Achieving Greater than $1 Billion in Annual Sales)" and "Outstanding Asia-Pacific Semiconductor Company" simultaneously Accelerates recovery from market downturn leveraging world-class HBM leadership; Global management performance recognized Reflects company's technology leadership and customer-centric execution SK Chairman Chey Tae-won emphasizes: "Technological competitiveness must remain unwavering in challenging times" Commits to driving new customer value and leading global AI market growth as a "Full-Stack AI Memory Creator" SEOUL, South Korea , Dec. 6, 2025 /PRNewswire/ -- SK hynix Inc. (or "the company", www.skhynix.com) announced today that it has been named the winner of the Best Financially Managed Semiconductor Company Award (Achieving Greater than $1 Billion in Annual Sales)[1] and the Outstanding Asia-Pacific Semiconductor Company Award[2] at the Global Semiconductor Alliance (GSA)[3] Awards 2025, held on December 4 PST in Santa Clara, California. [1] The Best Financially Managed Semiconductor Company Award : A category recognizing public semiconductor companies based on financial soundness and operational efficiency.
...keep reeding on prnewswire.com
HYT: Attractive Growth Potential As Interest Rates Decline
BlackRock Corporate High Yield Fund (HYT) earns a buy rating for its attractive price-to-NAV, robust 9.8% yield, and consistent monthly distributions. HYT's diversified portfolio, moderate leverage, and resilience across market cycles support its income stability, despite limited NAV growth and price appreciation. The fund's performance is highly sensitive to interest rate trends; a downward rate environment could enhance HYT's operating spread and share price.
...keep reeding on seekingalpha.com
The Best Stocks to Buy With $1,000 Right Now
Although stymied for the past few years, infrastructure construction projects are starting to ramp up again. Nvidia may be the hardware powerhouse of the AI movement for all the right reasons, but it's not the only game in town anymore.
...keep reeding on fool.com
Central Garden & Pet: Margin Strength Intact Despite Soft Demand
CENT demonstrates operational excellence, with FY25 marking a pivotal margin expansion and a resilient operating base. It's multi-year Cost & Simplicity program, portfolio reshaping, and facility consolidation have structurally improved margins, outpacing industry peers. Despite weak consumer confidence and $20M in incremental tariffs, CENT maintains disciplined cost controls and targets continued profit expansion in FY26.
...keep reeding on seekingalpha.com
Warren Buffett's Warning to Wall Street has Reached Deafening Levels: 3 Things You Should Do Before 2026.
Buffett has been selling stocks and building up a record level of cash for several quarters. His moves may inspire us to take valuable steps now that could support the long-term growth of our portfolios.
...keep reeding on fool.com
Rosen Law Firm Encourages Klarna Group plc Investors to Inquire About Securities Class Action Investigation – KLAR
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Klarna Group plc (NYSE: KLAR) resulting from allegations that Klarna may have issued materially misleading business information to the investing public. So What: If you purchased Klarna securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Ro.
...keep reeding on businesswire.com
3 Things to Watch With TGT Stock in 2026
Analysts sea a return to top- and bottom-line growth for Target in 2026. Keeping its yield high and its Dividend King streak going matter to income investors.
...keep reeding on fool.com
Trump Administration Waives Biden-Era Fine Against Southwest Airlines
The carrier won't have to pay $11 million related to its 2022 meltdown during the holiday season.
...keep reeding on wsj.com
Should You Buy Lululemon Stock Before 2026?
Lululemon got slammed by macroeconomic headwinds. However, the company's revenue is still growing but slowed significantly over the last year.
...keep reeding on fool.com
SNPS Investors Have Opportunity to Lead Synopsys, Inc. Securities Fraud Lawsuit
NEW YORK , Dec. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline. So What: If you purchased Synopsys securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
BGY: International Focused Call Writing Fund Delivering A Monthly Payout
BlackRock Enhanced International Dividend Trust (BGY) offers global equity exposure with a call writing strategy and currently trades at a -7.07% discount to NAV. BGY's discount has narrowed versus historical averages, making the fund appealing but not enough for a 'Buy'; I maintain a 'Hold' rating. The fund delivers an 8.84% monthly yield, primarily sourced from capital gains and option premiums, with a discount management program providing some downside support.
...keep reeding on seekingalpha.com
The Smartest Dividend Stock to Buy With $100 Right Now
Realty Income leases properties to resilient retail leaders. It has paid a monthly dividend for more than 55 years.
...keep reeding on fool.com
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Sprouts Farmers Market, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SFM
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026.
...keep reeding on newsfilecorp.com
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
NEW YORK , Dec. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
...keep reeding on prnewswire.com
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKYE
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Skye securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Rosen Law Firm Encourages Western Alliance Bancorporation Investors to Inquire About Securities Class Action Investigation - WAL
NEW YORK , Dec. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public. So what: If you purchased Western Alliance Bancorporation securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on prnewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the "Class Period"), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you purchased Primo Brands securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
― Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6 timepoint (n=12): mean absolute HbF in the 20 mg cohort increased by 9.9% at Week 6 (vs. 5.6% at Week 6 in the 12 mg cohort); 7 of 12 patients in the 20 mg cohort (58%) achieved absolute HbF levels ≥20% ―
...keep reeding on globenewswire.com
INTF: Low-Cost Option For International Factor Exposure
Launched in 2015, the iShares International Equity Factor ETF has outperformed plain vanilla international developed market ETFs in 2025 and over the past five years. INTF is overweight in cheap cyclical sectors such as financials and industrials, potentially delivering robust medium-term returns with above-average volatility. At the same time, INTF is underweight in information technology stocks, indicating more limited exposure to the AI trade.
...keep reeding on seekingalpha.com
What You Should Watch With RH Stock in 2026
RH stock is down nearly 60% this year. The company has faced a challenging housing market and new tariffs under the Trump administration.
...keep reeding on fool.com
Should You Buy Navitas Semiconductor Stock Before 2026?
Navitas is seeing growing interest from hyperscalers for its market-leading GaN and SiC technologies. Analysts forecast the company's revenue to fall in 2025 and 2026, but rebound sharply in 2027.
...keep reeding on fool.com
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI® (marstacimab) for adults and adolescents living with hemophilia A or B with inhibitors. The results demonstrated the superiority of HYMPAVZI in improving key bleeding outcomes compared to on-demand (OD) treatment with bypassing agents. HYMPAVZI was administered with a straightforward, once-weekly subcutaneous injection requiring minimal preparation and no tr.
...keep reeding on businesswire.com
ROSEN, A LEADING LAW FIRM, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRGO
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Perrigo securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
ROSEN, A LEADING AND RANKED FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?
Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and some upcoming catalysts.
...keep reeding on fool.com
What Is One of the Best Tech Stocks to Hold for the Next 10 Years?
The AI chip leader maintains a strong competitive position in providing the essential components to build next-generation data centers. Nvidia offers an attractive valuation relative to its growth prospects.
...keep reeding on fool.com
DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline.
...keep reeding on globenewswire.com
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 and November 6, 2025 (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sprouts Farmers Market, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SFM
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action on behalf of purchasers of securities and sellers of put options of Sprouts Farmers Market, Inc. (NASDAQ: SFM) between June 4, 2025 and October 29, 2025, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2026.
...keep reeding on globenewswire.com
Meta reportedly delays mixed reality glasses until 2027
Meta is developing new mixed reality glasses under the codename Phoenix, according to Business Insider — but their release date has been pushed back from the second half of 2026 to the first half of 2027.
...keep reeding on techcrunch.com
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
The Three Best Tech Stocks to Buy Before 2026
Alphabet, Micron, and Cisco are reasonably priced and experience lower volatility than most tech stocks. The three companies are value and growth hybrids, offering investors a rare opportunity to have both.
...keep reeding on fool.com
ROSEN, A RANKED AND LEADING FIRM, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRGO
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”), of the important January 16, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - STUB
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or traceable to the Registration Statement issued in connection with StubHub's September 2025 initial public offering (the "IPO"), of the important January 23, 2026 lead plaintiff deadline. SO WHAT: If you purchased StubHub common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Is This the Worst-Performing Tech ETF?
The ARK Innovation ETF is highly concentrated in 10 companies. It has made some bets on some poorly performing and unprofitable companies.
...keep reeding on fool.com
Trump administration waives $11 million fine for Southwest Airlines' 2022 holiday meltdown
The Trump administration said it will credit Southwest Airlines with $11 million from its fine over its 2022 holiday meltdown that stranded about 2 million customers. The Transportation Department in late 2023 ordered Southwest to pay a $140 million civil penalty for the holiday chaos the previous year.
...keep reeding on cnbc.com
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - JYD
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, both dates inclusive (the “Class Period”), of the important January 20, 2026 lead plaintiff deadline.
...keep reeding on globenewswire.com
If You'd Invested $1,000 in Robinhood 1 Year Ago, Here's How Much You'd Have Today
Robinhood's revenue doubled in the third quarter. Robinhood has shown signs of sustained profitability.
...keep reeding on fool.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Inspire Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on globenewswire.com
The Secret to Finding the Next Broadcom Is Hiding in Plain Sight
Broadcom has delivered huge returns over the past five years. The company's AI chips have played a key role in its success.
...keep reeding on fool.com
MLTX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action - MLTX
New York, New York--(Newsfile Corp. - December 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. SO WHAT: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Gotistobart demonstrated a clinically meaningful overall survival benefit compared to standard chemotherapy and a manageable safety profile in sqNSCLC
...keep reeding on globenewswire.com
Boeing says Trump's equity stake plan doesn't apply to big US defense firms
U.S. President Donald Trump's plan to take government equity stakes in strategic industries doesn't apply to major defense firms, the head of Boeing's defense unit said on Saturday, in contrast to previous comments by a senior government official.
...keep reeding on reuters.com